Is CSII a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

272 people get CSII articles and Market Currents by email alert.

Get email alerts on CSII »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Cardiovascular Systems Could Have A Much Higher Value To A Strategic Buyer
Stephen Simpson • Thu, Jan 17 • 11 Comments
Lee Ainslie's Maverick Capital Sells Cardiovascular Systems Warrants
Market Folly • Fri, Dec 3, 2010
Cardiovascular Systems Gains Traction
Rod Raynovich • Sun, Nov 7, 2010 • 1 Comment
Maverick Issues Correction on Cardiovascular Systems Holding
Market Folly • Fri, Apr 3, 2009
Maverick Capital Files 13G for Cardiovascular Systems
Market Folly • Tue, Mar 17, 2009

Cardiovascular Systems Could Have A Much Higher Value To A Strategic Buyer
Stephen Simpson • Thu, Jan 17 • 11 Comments

Top Medtech Analyst Points To Post-Obamacare Opportunities
Life Sciences Report • Thu, Sep 6, 2012
10 Medical Device Stocks Hedge Funds Are Buying Up
Kapitall • Fri, Aug 17, 2012 • 4 Comments
Pluristem Therapeutics' New Indication May Boost Company Valuation
Ray Dirks • Thu, May 17, 2012 • 12 Comments
Investors Waking Up To Pluristem's Developments
Ray Dirks • Thu, May 10, 2012 • 11 Comments
What's Wrong With Covidien?
Stephen Simpson • Fri, May 4, 2012 • 3 Comments
Spectranetics Still Searching For Traction In Peripheral
Stephen Simpson • Tue, Feb 21, 2012
AngioDynamics Sorely Testing Investor Patience
Stephen Simpson • Fri, Jan 6, 2012 • 2 Comments
17 High-Growth Healthcare Stocks Being Bought Up By Hedge Funds
Kapitall • Sun, Nov 20, 2011 • 2 Comments
How the Healthcare Sector Became Another Way to Play the Jobs Report
Stephen Simpson • Thu, Jul 28, 2011 • 2 Comments
30 Small Cap Stocks With Conservative Accounting Practices
Kapitall • Wed, Jan 12, 2011 • 3 Comments
Life Science Portfolios: Reflecting on a Year of Out-Performance
Rod Raynovich • Wed, Dec 29, 2010 • 1 Comment
PAD Awareness Month Brings Cardiovascular Companies to the Forefront
Douglas Cress • Thu, Sep 16, 2010
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
M. E. Garza • Wed, Jul 1, 2009

Cardiovascular's CEO Discusses F3Q2013 Results - Earnings Call Transcript
Wed, May 1
Cardiovascular Systems' CEO Discusses F2Q13 Results - Earnings Call Transcript
Wed, Jan 30
Cardiovascular Systems Inc. F3Q10 (Qtr End 03/31/10) Earnings Call Transcript
Wed, May 5, 2010

Cardiovascular Systems to Release Late-Breaking Coronary Data at C3 Conference

Business Wire (Wed, 11:26AM)
Cardiovascular Systems Unveils New Data from CONFIRM Study Series at the New Cardiovascular Horizons Conference

Business Wire (Jun 6, 2013)
Cardiovascular Systems to Unveil New Data from Confirm Study Series at NCVH Conference

Business Wire (Jun 4, 2013)
Cardiovascular Systems Enrolls First Patient in Liberty 360° Study

Business Wire (May 30, 2013)
Cardiovascular Systems Presents New Late-Breaking Coronary Results at EuroPCR Conference

Business Wire (May 23, 2013)
Cardiovascular Systems Releasing Late-Breaking ORBIT II Coronary Data at EuroPCR Conference

Business Wire (May 20, 2013)
Cardiovascular Systems Reports Fiscal 2013 Third-Quarter Financial Results

Business Wire (May 1, 2013)
Cardiovascular Systems to Webcast Fiscal 2013 Third-Quarter Earnings Conference Call Wednesday, May 1

Business Wire (Apr 24, 2013)
Cardiovascular Systems Prices Public Offering of Common Stock

Business Wire (Mar 20, 2013)
Cardiovascular Systems Announces Proposed Public Offering of Common Stock

Business Wire (Mar 19, 2013)
Cardiovascular Systems Completes PMA Submission of Orbital Atherectomy System for Coronary Artery Disease Treatment

Business Wire (Mar 15, 2013)
Cardiovascular Systems’ Orbital Atherectomy Technology Highlighted at ACC Innovations Forum

Business Wire (Mar 12, 2013)
Cardiovascular Systems Presents Results from Pivotal Coronary Trial at ACC

Business Wire (Mar 11, 2013)
Cardiovascular Systems to Present Pivotal Orbit II Coronary Data at the 2013 American College of Cardiology Conference

Business Wire (Mar 4, 2013)
CSI Presents Three-Year Orbit I Coronary Data at CRT 2013

Business Wire (Feb 25, 2013)
Cardiovascular Systems Sponsoring Orbital Atherectomy Sessions at iCON 2013

Business Wire (Feb 19, 2013)
Cardiovascular Systems to Present Three-Year Orbit I Coronary Data at 2013 Cardiovascular Research Technologies Conference

Business Wire (Feb 19, 2013)
Cardiovascular Systems Reports Fiscal 2013 Second-Quarter Financial Results

Business Wire (Jan 30, 2013)
Cardiovascular Systems to Webcast Fiscal 2013 Second-Quarter Earnings Conference Call Wednesday, Jan. 30

Business Wire (Jan 25, 2013)
CSI Presents Late-Breaking Data at ISET 2013

Business Wire (Jan 23, 2013)

CSII vs. ETF Alternatives

Company Description

Currently, there's no company description for CSII.

Sector: Healthcare

Industry: Medical Appliances & Equipment

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, June 6, 3:23 PM Cardiovascular Systems (CSII -0.6%) releases new data on a study evaluating its orbital atherectomy system, a treatment for peripheral arterial disease in above and below the knee lesions. About 81% of the lesions treated had severe or moderate calcification-historically considered a difficult patient population to treat. The results showed low rates of procedural events, regardless of arterial calcium burden. Comment! [Healthcare]
Thursday, May 30, 3:24 PM Cardiovascular Systems (CSII +0.4%) says it's enrolled the first patient in Liberty 360 study, a post-market evaluation of the acute and long-term clinical and economic effectiveness of its orbital atherectomy system in treating peripheral arterial disease. The study is unique in that it evaluates success based on long-term outcomes and durability, rather than acute angiographic results of the various treatments. Comment! [Healthcare]
Thursday, May 2, 6:26 AM Cardiovascular Systems (CSII): Q1 EPS of -$0.29 beats by $0.03. Revenue of $26.5M beats by $0.5M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, March 20, 10:21 AM Cardiovascular Systems (CSII +4%) gains this morning after pricing its 2M secondary offering at $17.60, just a mere a 1% discount to Tuesday's close. The medical device company, says it wants to use the proceeds for working capital and general corporate needs - which likely includes further funding of its Orbit II trials, a treatment therapy for severely calcified coronary lesions. The company's current float is around 21.1M shares. Comment! [Healthcare, On the Move]
Monday, March 11, 11:16 AM Cardiovascular Systems (CSII +11%) rallies after the company says Orbit II trials of its treatment therapy for patients with severely calcified coronary lesions had exceeded expectations by a significant margin. The study is reviewing the safety and effectiveness of it's orbital atherectomy technology and is the first Investigational Device Exemption study to seek approval for treating these lesions. Comment! [Healthcare, On the Move]
Thursday, January 31, 4:09 PM Despite the marketshare gains Cardiovascular Systems (CSII) has made with its Diamondback and Stealth devices for treating narrowed or blocked arteries in the leg, the real value in the company may lie in its takeout potential, says Seeking Alpha contributor Stephen Simpson. CR Bard, Cook, BSX, JNJ, MDT and ABT all have sales forces in the peripheral treatment space, making them solid candidates for a possible buyout of CSII. Comment! [Healthcare, M&A]
Thursday, January 31, 3:42 PM Cardiovascular Systems (CSII +15%) gains today after reporting a better-than-expected Q2 net loss of $0.28 per share, $0.05 wider than a year ago but nonetheless beating analyst expectations. Revenue climbed 28% Y/Y, as conversions to the company's Stealth 360 treatment for peripheral artery disease continued at a high rate, representing 93% of total device revenues for the quarter. Revenue from office-based labs also climbed at a double-digit pace. Comment! [Healthcare, On the Move, Earnings]
Thursday, January 31, 12:45 PM Midday top 10 gainers: ORCC +82%. WMS +52%. FTNT +24%. HHS +22%. EDMC +18%. BTUI +18%. JDSU +18%. PBI +17%. CSII +16%. SGI +16%.
Midday top 10 Losers: CLSN -81%. LQDT -24%. STZ -20%. NVGN -18%. FIO -16%. HALO -16%. RDEN -14%. USAK -13%. HAR -13%. JBSS -12%. Comment! [On the Move]
Thursday, January 31, 4:38 AM Cardiovascular Systems (CSII): FQ2 EPS of -$0.28 beats by $0.03. (PR) Comment! [Earnings, Breaking News, On the Move]
Thursday, May 3, 2012, 12:50 PM Cardiovascular Systems (CSII +2.5%) trades higher after William Blair upped the shares to Outperform earlier today, citing an improved growth trajectory on the back of the company's Q3 results. Comment! [Healthcare, On the Move]
Thursday, October 6, 2011, 4:19 PM Cardiovascular Systems (CSII) guides its FQ1 lower, now seeing revenue at $18.7M. The company says a shift in peripheral arterial disease procedures to physician-based labs caused hospital-based procedures and related purchases to decrease. Shares -7.9% AH. Comment! [Healthcare, On the Move]
Wednesday, February 2, 2011, 4:39 PM Cardiovascular Systems (CSII) was one of the relatively few medical device stocks to really outperform in 2010, but will a slight miss and revised guidance bring an end to the optimism? Comment! [Healthcare]

CSII Cardiovascular Systems, Inc.

CSII

Cardiovascular Systems, Inc.